Advertisement
UK markets closed

  • FTSE 100

    8,433.76
    +52.41 (+0.63%)
     

  • FTSE 250

    20,645.38
    +114.08 (+0.56%)
     

  • AIM

    789.87
    +6.17 (+0.79%)
     

  • GBP/EUR

    1.1622
    +0.0011 (+0.09%)
     

  • GBP/USD

    1.2525
    +0.0001 (+0.01%)
     

  • Bitcoin GBP

    48,528.49
    -1,656.33 (-3.30%)
     

  • CMC Crypto 200

    1,261.13
    -96.88 (-7.13%)
     

  • S&P 500

    5,222.68
    +8.60 (+0.16%)
     

  • DOW

    39,512.84
    +125.08 (+0.32%)
     

  • CRUDE OIL

    78.20
    -1.06 (-1.34%)
     

  • GOLD FUTURES

    2,366.90
    +26.60 (+1.14%)
     

  • NIKKEI 225

    38,229.11
    +155.13 (+0.41%)
     

  • HANG SENG

    18,963.68
    +425.87 (+2.30%)
     

  • DAX

    18,772.85
    +86.25 (+0.46%)
     

  • CAC 40

    8,219.14
    +31.49 (+0.38%)
     
MONEY:

Best savings accounts that offer above inflation rates

How to earn the most interest on your savings

CBD in Food: The Market for Ingestible Products

Research and Markets
·2-min read

Dublin, Sept. 04, 2020 (GLOBE NEWSWIRE) -- The "CBD as a Novel Food: The Future for Edibles in Europe" report has been added to ResearchAndMarkets.com's offering.

The question of Novel Food approval is the single biggest issue facing the CBD edibles market, and perhaps the entire CBD market, in Europe. Hopes that there might be an easy way around the regulatory requirement seem unrealistic, and understanding exactly what the Novel Food process entails must therefore now be a top priority for any player hoping to market mainstream CBD products in Europe.

This report examines key aspects and drivers of the edibles market itself before looking in detail at the Novel Food regulations, both at EU level and in non-EU markets: notably the UK, as well as Switzerland and Norway. Questions it considers and answers include whether CBD really is novel, whether approvals are likely to be generic or applicant-specific, how the Novel Food Catalogue and RASFF operate, and the costs of Novel Food applications.

It will enable companies to make a rounded, informed decision on whether to pursue Novel Food approval - and if they decide to do so, how to proceed with their application. Detailed information on regulatory requirements is complemented by an assessment of the business impacts of the Novel Foods regime, enabling companies to take a joined-up approach to their strategy on CBD edibles in Europe.

ADVERTISEMENT

Special attention is also given to UK regulation, which differs from the EU's in key aspects - understanding this is an essential prerequisite to taking advantage of the UK's more liberal regime.

Key Topics Covered:

1. Executive Summary
2. Introduction: What is CBD?
3. Is CBD in Food Really Novel?
4. CBD in Food: the Market for Ingestible Products
5. Novel Food Regulations in the EU
6. The Regulation of Novel Foods in the UK
7. Other Non-EU Countries
8. Industry Impact of Novel Food Applications: the Costs
9. Industry Impact of Novel Food Applications: the Benefits
10. Conclusion: What Does the Future Hold for the CBD Sector in Europe?

For more information about this report visit https://www.researchandmarkets.com/r/wgghpy

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900